Search Results
Results found for "Émile Breault"
- Trainee Symposium I
Characterization of Novel Opioid-Neurotensin Bifunctional Ligands Designed to Target Pain Management About Émile Breault "Emile Breault is undertaking his master's degree in pharmacology at the university of Sherbrooke Émile Breault on the web Google Scholar ResearchGate Dr.
- GPCR Retreat Schedule 2023
PM Trainee Symposium I Eric Johansen , Johns Hopkins University Grace Mazarura , McGill University Émile Breault, Université de Sherbrooke Bassam Albraidy , Ottawa Hospital Research Institute Read More Thursday
- Dr. Paul J. Gasser | Dr. GPCR Ecosystem
I received my PhD in Biology at Arizona State University, where I worked in the lab of Miles Orchinik
- Disrupting VIPR2 dimerisation halts breast cancer spread—could TM3-4 peptides be the next breakthrough in targeted cancer therapy? Check out the latest GPCR news in the Ecosystem today! You’ll need to register but don’t worry, it’s Free! ➡️ https://www.ecosystem.drgpcr.com/gpcrs-in-oncology-and-immunology/dimerisation-of-the-vip-receptor-vipr2-is-essential-to-its-binding-vip-and-g%CE%B1i-proteins%2C-and-to-its-functions-in-breast-cancer-cells #gpcr#drgpcr | Dr. GPCR Ecosystem
Home → Flash News → Disrupting VIPR2 dimerisation halts breast cancer spread—could TM3-4 peptides be dimerisation-of-the-vip-receptor-vipr2-is-essential-to-its-binding-vip-and-g%CE%B1i-proteins%2C-and-to-its-functions-in-breast-cancer-cells gpcr#drgpcr Published on May 12, 2025 Category GPCR Weekly News Disrupting VIPR2 dimerisation halts breast dimerisation-of-the-vip-receptor-vipr2-is-essential-to-its-binding-vip-and-g%CE%B1i-proteins%2C-and-to-its-functions-in-breast-cancer-cells
- Do you know that dilated cardiomyopathy, a disease that makes it harder for the heart to pump blood to the rest of the body, results from the deficiency of Latrophilin-2? Check out this paper to understand the function of Latrophilin-2 and how it leads to dilated cardiomyopathy. Subscribe to the Dr. GPCR Newsletter 📰 and get the latest GPCR News delivered to your inbox. | Dr. GPCR Ecosystem
cardiomyopathy, a disease that makes it harder for the heart to pump blood to the rest of the body, results cardiomyopathy, a disease that makes it harder for the heart to pump blood to the rest of the body, results
- Did you know that certain ergot derivatives can produce wash-resistant signalling through the 5-HT2B receptor persisting for many hours without losing potency or efficacy? By using signalling assays, radioligand binding assay, and microscopy, Gaidarov et al. suggested that this phenomenon results from persistently/irreversibly internalised signalling receptor complexes. Check out the latest GPCR news in the Ecosystem today! You’ll need to register but don’t worry, it’s Free! ➡️ https://www.ecosystem.drgpcr.com/receptor-activation-and-signaling/mechanisms-of-constitutive-and-agonist-induced-5-ht2b-internalization%2C-persistent-endosomal-signaling-and-paradoxical-regulation-of-agonist-pharmacology #gpcr#drgpcr | Dr. GPCR Ecosystem
signalling assays, radioligand binding assay, and microscopy, Gaidarov et al. suggested that this phenomenon results signalling assays, radioligand binding assay, and microscopy, Gaidarov et al. suggested that this phenomenon results
